Cotargeting of Mitochondrial Complex I and Bcl-2 Shows Antileukemic Activity against Acute Myeloid Leukemia Cells Reliant on Oxidative Phosphorylation
Targeting oxidative phosphorylation (OXPHOS) is a promising strategy to improve treatment outcomes of acute myeloid leukemia (AML) patients. IACS-010759 is a mitochondrial complex I inhibitor that has demonstrated preclinical antileukemic activity and is being tested in Phase I clinical trials. Howe...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | angličtina |
Vydáno: |
2020
|
On-line přístup: | https://doi.org/10.3390/cancers12092400 https://www.mdpi.com/2072-6694/12/9/2400/pdf?version=1598276385 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|